Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog

Int J Urol. 2006 Apr;13(4):457-9. doi: 10.1111/j.1442-2042.2006.01325.x.

Abstract

Vesicouterine fistula is a rare complication of cesarean section. Although surgical repair was mandatory for the management of the fistula previously, a recent review showed high efficacy of hormonal manipulation by the induction of amenorrhea. Herein, we report a new case of vesicouterine fistula secondary to cesarean section successfully treated by luteinizing hormone-releasing hormone analog for 6 months. Conservative hormonal treatment for vesicouterine fistula caused by cesarean section should be considered before surgical repair.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cystoscopy
  • Female
  • Fertility Agents, Female / administration & dosage
  • Fertility Agents, Female / therapeutic use*
  • Follow-Up Studies
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Humans
  • Injections, Subcutaneous
  • Leuprolide / administration & dosage
  • Leuprolide / therapeutic use*
  • Magnetic Resonance Imaging
  • Urinary Bladder Fistula / diagnosis
  • Urinary Bladder Fistula / drug therapy*
  • Uterine Diseases / diagnosis
  • Uterine Diseases / drug therapy*

Substances

  • Fertility Agents, Female
  • Gonadotropin-Releasing Hormone
  • Leuprolide